<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-22T17:15:42Z</responseDate><request verb="GetRecord" identifier="oai:www.repository.cam.ac.uk:1810/391672" metadataPrefix="uketd_dc">https://api.repository.cam.ac.uk/server/oai/request</request><GetRecord><record><header><identifier>oai:www.repository.cam.ac.uk:1810/391672</identifier><datestamp>2025-12-21T02:02:34Z</datestamp><setSpec>com_1810_263984</setSpec><setSpec>com_1810_221767</setSpec><setSpec>com_1810_256067</setSpec><setSpec>col_1810_263986</setSpec></header><metadata><uketd_dc:uketddc xmlns:uketd_dc="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:uketdterms="http://naca.central.cranfield.ac.uk/ethos-oai/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/ http://naca.central.cranfield.ac.uk/ethos-oai/2.0/uketd_dc.xsd">
   <dc:title>A Leap of Fate: Fluid identity, functional modules, and flexible strategies for  transcription factor-based reprogramming</dc:title>
   <dc:identifier xsi:type="dcterms:DOI">https://doi.org/10.17863/CAM.122715</dc:identifier>
   <dc:creator>Fennell, Thea</dc:creator>
   <uketdterms:advisor>Scheres, Sjors</uketdterms:advisor>
   <dcterms:abstract>“The most important reason for going from one place to another is to see what’s in between,  and they took great pleasure in doing just that.” – Norton Juster, The Phantom Tollbooth

Direct cell reprogramming is a technique used to convert a cell from one type to another,  without a stable intermediate. This is commonly achieved through transcription  factor  (TF)  over-expression in  the  source cell  type, with TF selection based primarily on  the  target cell type. Historically, most trial TF panels designed for reprogramming have been  selected on the basis of developmental literature or reports of prior trials. However, with  advancing  computational  capacity  and  increasing  availability  of  transcriptomic  and  regulatory datasets, quantitative predictive frameworks (e.g. Mogrify) are now feasible.  This offers the opportunity to streamline TF selection and thus reprogramming.

Such  methods  may  also  open  the  possibility  of  new  applications,  including  to  target  secondary or synthetic cell types or to conduct conversions within non-model species, for  which  there  may  be  limited  prior  literature  in  the  field.  This  thesis  explores  these  possibilities, with a view  to how  flexibility in  framework implementation can increase  applicability. It also considers how these methodological trials can inform our theoretical  model of cell identity, beyond the classic Waddington differentiation landscape, for the  future manipulation of non-standard cell types. Overall, the thesis comprises 5 chapters,  grouped by thematic relevance into 3 sections.

In  Section  I,  the  principle  of  integrating  differential  expression  (DE)  and  regulatory  network analysis to identify phenotype-critical TFs is illustrated, both beyond (Chapter  1) and within (Chapter 2) the context of an automated predictive framework, i.e. Mogrify.  Chapter 1 describes the application of DE to an idiopathic pulmonary fibrosis (IPF) bulk  RNA-seq  dataset  from  mouse  lung  tissue  to  determine  transcriptomic  differences  between  diseased  and  healthy  tissue  and  between  resistant  and  susceptible  strains.  Regulatory enrichment analysis of the results shows that targets of the anti-fibrotic TF  FOSL1 are overrepresented in  the cross-strain expressed gene  (DEG) set, suggesting a  possible effect of FOSL1 on IPF risk.

Chapter 2 describes the use of Mogrify to predict TFs for the conversion of fibroblasts and  induced pluripotent stem cells (iPSCs) to erythrocytes and megakaryocytes. Despite the  developmental similarity of these target cell types, the TF prediction sets were distinct.  This indicates potential capacity of the framework to identify regulators responsible for  differences between these related targets as well as between source and target cell types. 
In Section  II, innovation around  the Mogrify  framework and handling of predictions is  introduced.

Chapter  3  describes  the  transcriptomic  characterisation  of  cells  resulting  from the reprogramming protocol designed in Chapter 2 – as well as those resulting from  of a second, literature-based protocol – using both single-cell and bulk RNA-seq. Crucially,  bulk data was also an input to secondary Mogrify implementation, providing predictions  for improvement of reprogrammed cells that are detailed in this chapter.  Additionally,  Chapter 3 compares TF predictions  from iPSC  to blood-derived and synthetic myeloid  cells, as well as from iPSC and synthetic myeloid cells toward blood-derived myeloid cells.

Chapter  4  handles  the  flexible  implementation  of  Mogrify  to  predict  TFs  for  the  conversion  of  CHOK1  cells  to  hamster  plasma  cells.  It  describes  the  use  of  orthologue  mapping as an adaptive measure  to  facilitate  the input of CHOK1 and hamster data  to  Mogrify,  which  required  either  human  or  mouse  annotation.  Inter-run  comparison  is  again  detailed, as  the  single-cell  CHOK1  to  hamster  plasma  cell  data is  complemented  with single-cell and bulk CHOK1 and mouse and human plasma cell data, as well as single-cell  hamster  B  cell  data.  A  co-expression  analysis  of  the  results  of  reprogramming  suggests  that  this  protocol may  constitute an improvement  on  the existing method  of  XBP1 or PRDM1/BLIMP1 over-expression.

Chapter 5 attempts to address how predictive framework might be adapted for the design  of a truly synthetic cell type: a functionally defined target cell. It proposes the concept of  a reprogramming dictionary, comprising  functionally annotated and co-regulated gene  modules. As proof-of-principle, this is piloted through the construction of co-expressed  gene modules from the Tabula Sapiens, annotated on the basis of functional enrichment.  The expression of  these modules is also calculated and reported  for a test lung cancer  dataset. Many modules are noted to recombine relative to the reference dataset, including  those not functionally enriched. Some cancer cells are noted to recombine normal cellular  functions  with  tumorigenic  ones  – illustrating  in  reverse  the  dictionary’s  intended  purpose of function-defined non-standard cell type design. Further development of the  dictionary concept – and its forward application– is left as an open problem.</dcterms:abstract>
   <uketdterms:institution>University of Cambridge</uketdterms:institution>
   <dcterms:issued>2025-03-31</dcterms:issued>
   <dc:type>Thesis</dc:type>
   <uketdterms:qualificationlevel>Doctoral</uketdterms:qualificationlevel>
   <uketdterms:qualificationname>Doctor of Philosophy (PhD)</uketdterms:qualificationname>
   <dc:language>eng</dc:language>
   <uketdterms:sponsor>Medical Research Council studentship</uketdterms:sponsor>
   <dcterms:isReferencedBy xsi:type="dcterms:URI">https://www.repository.cam.ac.uk/handle/1810/391672</dcterms:isReferencedBy>
   <uketdterms:embargotype>embargo</uketdterms:embargotype>
   <uketdterms:embargodate>2026-10-31</uketdterms:embargodate>
   <dc:identifier xsi:type="dcterms:URI">https://www.repository.cam.ac.uk/bitstreams/08c85b39-0c2b-47c5-85c0-63c7d4310c9a/download</dc:identifier>
   <uketdterms:checksum xsi:type="uketdterms:MD5">49ae8f62c756fd4db20a4dd60762cfda</uketdterms:checksum>
   <dcterms:license>https://www.repository.cam.ac.uk/bitstreams/1ad5e057-27e3-4654-b37b-0a0d34759f26/download</dcterms:license>
   <uketdterms:checksum xsi:type="uketdterms:MD5">87eda9de84448d1f82354d60eee3eb5f</uketdterms:checksum>
   <dc:rights>http://purl.org/NET/rdflicense/allrightsreserved</dc:rights>
   <dc:subject>Direct cell reprogramming</dc:subject>
   <dc:subject>Transcriptomics</dc:subject>
   <dc:subject>RNA-seq</dc:subject>
   <dc:subject>Single-cell</dc:subject>
   <dc:subject>Synthetic biology</dc:subject>
</uketd_dc:uketddc>
</metadata></record></GetRecord></OAI-PMH>